參考文獻/References:
[1] ITZYKSON R,FOURNIER E,BERTHON C,et al.Genetic identification of patients with AML older than 60 achieving long-term survival with intensive chemotherapy[J].Blood,2021,138(7):507-519.
[2] 王寧,金敬一,陳麗華.免疫分子對CD4+ Tregs的調(diào)節(jié)作用[J].免疫學雜志,2018,34(1):73-79.
[3] 郭智,舒榕,王強.CD4+CD25+調(diào)節(jié)性T細胞在造血干細胞移植后誘導免疫耐受的作用[J].生命的化學,2020,40(1):75-79.
[4] BAI Y,HE T,ZHANG L,et al.Prognostic value of FOXP3 regulatory T cells in patients with diffuse large B-cell lymphoma:a systematic review and meta-analysis[J].BMJ Open,2022,12(9):e060659.
[5] QIU Y,KE S,CHEN J,et al.Foxp3+ regulatory T cells and the immune escape in solid tumours[J].Front Immunol,2022,13:982986.
[6] 安田麗,李亮亮,趙麗.骨髓微環(huán)境影響調(diào)節(jié)性T細胞促進血液惡性腫瘤發(fā)展的研究進展[J].中國免疫學雜志,2021,37(5):635-640,
[7] JAUNG J,CHO B S,KIM H J,et al.Reclassification of acute myeloid leukemia according to the 2016 WHO classification[J].Ann Lab Med,2019,39(3):311-316.
[8] HAFERLACH T,SCHNITTGER S,KERM W,et al.Genetic classification of acute myeloid leukemia(AML)[J].Ann Hematol,2004,83(Suppl 1):S97-S100.
[9] ARIK D,BENLI T,TELLI E.Number of Foxp3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma[J].J Gynecol Oncol,2023,34(2):e16.
[10] 劉洪博,王文智,石慶芳.NK細胞和Tregs細胞亞群在宮頸癌患者外周血中表達及臨床意義[J].中國老年學雜志,2020,4(2):284-287.
[11] NOROUZIAN M,MEHDIPOUR F,ASHRAF M J,et al.Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck[J].BMC Immunol,2022,23(1):56.
[12] 柯星,張良,沈立松.CD4+CD25highCD127low調(diào)節(jié)性T細胞促進上皮性卵巢癌轉(zhuǎn)移機制的初步探討[J].檢驗醫(yī)學,2019,34(2):110-115.
[13] 張勇.腫瘤微環(huán)境中CD4+Foxp3+Tregs對鼻咽癌患者預后影響[J].中國實驗診斷學,2019,23(10):1723-1727.
[14] 陳熙勐,張皓旻,楊波,等.急性髓系白血病患者預后不良相關基因的多組學分析[J].中國實驗血液學雜志,2019,27(2):331-338.
[15] DONG Y,HAN Y,HUANG Y,et al.PD-L1 is expressed and promotes the expansion of regulatory T cells in acute myeloid leukemia[J].Front Immunol,2020,11:1710.
[16] WANG M,ZHANG C,TIAN T,et al.Increased regulatory T cells in peripheral blood of acute myeloid leukemia patients rely on tumor necrosis factor(TNF)-α-TNF receptor-2 pathway[J].Front Immunol,2018,9:1274.
[17] ARANDI N,RAMZI M,SAFAEI F,et al.Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype[J].Blood Res,2018,53(4):294-298.